miRecule, Inc. Email Format
Biotechnology ResearchMaryland, United States11-50 Employees
miRecule, Inc. is a biotechnology research company based in Gaithersburg, Maryland, focused on developing first-in-class RNA-based therapies. Its lead programs target Head & Neck Squamous Cell Carcinoma and Facioscapulohumeral Muscular Dystrophy, with an approach that leverages genomic patient data to tailor therapeutics to individual genetic profiles. The company emphasizes identifying disease-causing genetic changes using its DREAmiR platform and then creating RNA therapeutics designed to correct those abnormalities, aiming to deliver treatments that address the specific needs of patients. Through strategic collaborations and a focus on precision medicine, miRecule operates within the biotechnology field as an innovator in RNA therapeutics. A recent development notes recognition of an executive for commercialization efforts, reflecting ongoing activity in advancing its programs and collaborations.